BOC Sciences Revenue and Competitors

Shirley, NY USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • BOC Sciences's estimated annual revenue is currently $4M per year.(i)
  • BOC Sciences's estimated revenue per employee is $155,000

Employee Data

  • BOC Sciences has 26 Employees.(i)
  • BOC Sciences grew their employee count by 8% last year.

BOC Sciences's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.6M4-20%N/AN/A
#2
$6.7M438%N/AN/A
#3
$34.4M222-1%N/AN/A
#4
$5.2M670%$10MN/A
#5
$2M130%N/AN/A
#6
$7.5M370%$51.6MN/A
#7
$0.3M2-50%N/AN/A
#8
$4.3M21-16%$3.3MN/A
#9
$3.6M230%N/AN/A
#10
$4.3M56-8%$118MN/A
Add Company

What Is BOC Sciences?

BOC Sciences provides a wide variety of custom services which range from bulk compounds to specialty species in the pharmaceutical, agrochemical, and biotechnology industries. We are committed to providing our customers with the best products and services at the most competitive prices. Given diverse packing options for most of our chemicals, you are welcome to order the desired compounds in any quantities from a few mg to several kg along with all the relevant technical reports. We sincerely hope that our unremitting pursuits of excellence, success, and professionalism will add immense value to your research and development projects!

keywords:chemical supplier, CDMO, chemical synthesis

N/A

Total Funding

26

Number of Employees

$4M

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

BOC Sciences News

2022-04-20 - Arbidol Hcl Market Share 2022-2030| Key Players ...

Arevipharma; BOC Sciences; CSPS; Simcere; Jiangsu Wuzhong Pharmaceutical Group; Jiangsu Wuzhong Group; Shijiazhuang Zhongshuo Pharma; Autran.

2022-04-17 - BOC Sciences Unveils Comprehensive Custom Synthesis ...

BOC Sciences adapts the latest and most productive technologies to synthesize targets by chemical manipulation to satisfy all needs of global...

2022-04-13 - BOC Sciences Actively Engages in TIDES USA 2022

BOC Sciences recently announces its participation in TIDES USA: Oligonucleotide & Peptide Therapeutics-the largest and most renowned...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.3M26-7%N/A
#2
N/A288%N/A
#3
$4.1M330%$45M
#4
$8.5M435%N/A
#5
$9.3M4310%N/A